Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated

Miao Huang1, Yinong Chen2, Chenyu Liang1

  • 1Department of Mechanical and Aerospace Engineering, Herbert Wertheim College of Engineering, University of Florida, Gainesville, FL, 32610, USA; UF Health Cancer Center, University of Florida, Gainesville, FL, 32610, USA.

Biomaterials
|December 24, 2025
PubMed

Insights

Drug-resistant lung cancer cells are more sensitive to mechanical forces. Targeting this mechanosensitivity, particularly YAP nuclear localization, offers a new strategy to eliminate resistant cancer cells and improve treatment outcomes.

Area of Science:

  • Oncology
  • Mechanobiology
  • Biophysics

Background:

  • Drug resistance is a major challenge in cancer therapy, leading to treatment failure and recurrence.
  • Developing novel strategies to eliminate drug-resistant cancer cells (DRCs) is crucial for improving patient outcomes.
  • Non-small cell lung cancer (NSCLC) is a significant cause of cancer-related mortality.

Purpose of the Study:

  • To investigate the mechanical sensitivity of drug-resistant NSCLC cells.
  • To explore novel therapeutic strategies targeting the unique properties of DRCs.
  • To elucidate the mechanisms underlying the heightened mechanosensitivity of DRCs.

Main Methods:

  • In vitro mechanical stimulation assays comparing drug-resistant cancer cells (DRCs) and drug-susceptible cancer cells (DSCs).
  • Quantitative imaging, transcriptomic profiling, and pharmacological evaluations to analyze cellular responses.
  • Analysis of YAP (Yes-associated protein) translocation and nuclear localization in response to mechanical stimuli.
  • In vivo studies using NSCLC patient-derived organoid models and patient tissues.

Main Results:

  • DRCs exhibit significantly increased sensitivity to mechanical stimuli compared to DSCs.
  • A soft culture microenvironment combined with targeted therapies reduces DRC survival by modulating YAP translocation.
  • DRCs show heightened YAP nuclear localization in patient-derived organoids and tissues.
  • Alterations in nuclear force sensing, not actomyosin contractility or Hippo-YAP pathway activation, drive YAP mechanosensitivity in DRCs.

Conclusions:

  • Drug-resistant NSCLC cells possess a unique mechanosensitivity that can be therapeutically exploited.
  • Targeting YAP mechanosensitivity presents a promising novel strategy to overcome drug resistance in NSCLC.
  • This research opens new avenues for mechanobiological interventions in cancer therapy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Tension Response at Adherens Junctions01:26

Tension Response at Adherens Junctions

The adherens junctions that anchor cells together are multi-protein complexes that dynamically adapt to mechanical stimuli such as tensile forces and shear stress. Mechanosensory proteins in these junctions can sense such mechanical stimuli and undergo a shift in their conformation, resulting in an altered function — a process called mechanotransduction.
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cell-matrix's Response to Mechanical Forces01:13

Cell-matrix's Response to Mechanical Forces

In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. 
Anchoring junctions mechanically attach a cell to the...
3.4K